Pulmonary Embolism
📧 Sign up to get email alerts when something new happens for Pulmonary Embolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Prospective Investigation of Pulmonary Embolism Diagnosis III
This document reports the completion status of a prospective clinical trial investigating pulmonary embolism diagnosis (Pulmonary Embolism D…
-
CLINICAL_TRIALS research · 2013-07-19Clinical Trial Update: The Risk of Venous Clotting in Patients After Renal Transplant
This ClinicalTrials.gov entry describes a study on the risk of venous clotting in renal transplant recipients, sponsored by St. Joseph's Hea…
-
FDA approval · 2013-06-05FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for enoxaparin sodium (Lovenox) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: The Study of Warfarin Maintenance Dose in Chinese Patients
This document provides an update on a clinical trial evaluating the maintenance dose of warfarin in Chinese patients with atrial fibrillatio…
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: A Pivotal Study to Evaluate the Safety and Effectiveness of RMT Medical Technology's SafeFlo® Vena Cava Filter [NA]
A pivotal trial evaluating the safety and effectiveness of the SafeFlo Vena Cava Filter by RMT Medical Technologies has completed. The study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-05-30Clinical Trial Update: Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy [Phase 4]
A Phase 4 clinical trial evaluating fondaparinux for treating pulmonary embolism has been withdrawn. The study aimed to assess whether fonda…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Study Of Lybrel In Relation To Venous Thromboembolism
A completed clinical trial assessed whether Lybrel influences the risk of venous thromboembolism, with results posted in 2013.
-
FDA approval · 2013-05-20FDA Approved: HEPARIN SODIUM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Hospira's heparin sodium, indicating a modification to the product's approval (likely labeling o…
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: Safety Study of the Angel™ Catheter in Subjects With Risk of Pulmonary Embolism [Phase 1]
Phase 1 safety study of the Angel Catheter in subjects at risk of pulmonary embolism has completed, with results posted in 2013 by BiO2 Medi…
-
CLINICAL_TRIALS safety_alert · 2013-05-07Clinical Trial Update: Thromboembolic Complications After Pacemaker or Implantable Cardioverter-Defibrillator Procedures
This clinical trial update highlights thromboembolic complications after pacemaker or implantable cardioverter-defibrillator procedures and …
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Prognostic Factors for Acute Pulmonary Embolism in Critically Ill Patients
This clinical trial update reports on prognostic factors for acute pulmonary embolism in critically ill patients and indicates the study has…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Radiation Dose From Computed Tomography Before and After Implementation of a High Pitch Dual Spiral Technique
A completed clinical trial update evaluating the radiation dose of computed tomography before and after implementing a high-pitch dual-spira…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2) [Phase 2]
Phase 2 trial ONYX-2 evaluating YM150, a Factor Xa inhibitor by Astellas, for prevention of venous thromboembolism after hip replacement; th…
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Accuracy of Multi-organ Ultrasound for the Diagnosis of Pulmonary Embolism
The completed trial evaluated the accuracy of multi-organ ultrasound for diagnosing pulmonary embolism.
-
FDA approval · 2013-03-04FDA Approved: DRAXIMAGE MAA — Supplemental Application (Jubilant DraxImage Inc)
FDA approved a supplemental application for the DRAXIMAGE MAA kit used to prepare Tc-99m albumin aggregated for lung perfusion imaging, incl…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity
A completed clinical trial evaluated the accuracy and precision of the INRatio Prothrombin Time monitoring system using a new low-volume, he…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study [Phase 3]
The EINSTEIN PE Phase 3 trial evaluated rivaroxaban for the treatment of acute symptomatic pulmonary embolism, with results posted in Januar…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Detection of Pulmonary Embolism With Low-dose CT Pulmonary Angiography [NA]
A completed clinical trial evaluated the use of low-dose CT pulmonary angiography for detecting pulmonary embolism. The study was conducted …
-
FDA approval · 2013-01-10FDA Approved: HEPARIN SODIUM IN SODIUM CHLORIDE — Supplemental Application (B. Braun Medical Inc.)
FDA approves a supplemental application for HEPARIN SODIUM IN SODIUM CHLORIDE from B. Braun Medical Inc., expanding its labeling for anticoa…
-
FDA approval · 2012-12-19FDA Approved: PRADAXA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals Inc.)
FDA approved a supplemental application for Pradaxa (dabigatran etexilate mesylate) from Boehringer Ingelheim Pharmaceuticals Inc., to modif…
-
CLINICAL_TRIALS trial_result · 2012-12-19Clinical Trial Update: The Visualization of Uncertainty in Clinical Diagnostic Reasoning for Pulmonary Embolism [NA]
A completed University of Calgary clinical trial investigating visualization of uncertainty in the diagnostic reasoning process for pulmonar…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures [Phase 2, Phase 3]
A Phase 2/Phase 3 trial is evaluating thromboprophylaxis for patients with below-knee plaster immobilization after ankle/foot fractures to p…
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm [Phase 4]
Phase 4 clinical trial comparing warfarin dosing using a decision-model approach versus a pharmacogenetic algorithm; results were posted in …
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption [Phase 4]
PREPIC 2 is a Phase 4 trial examining whether vena cava interruption with an inferior vena cava filter can prevent recurrent pulmonary embol…
-
FDA approval · 2012-11-02FDA Approved: XARELTO — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for XARELTO (rivaroxaban) filed by Janssen Pharmaceuticals, Inc.